Clinical Trial: Efficacy and Safety of Ivarmacitinib in the Treatment of Severe Alopecia Areata: A Real-World Clinical Study (China)

China, Sept. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Ivarmacitinib in the Treatment of Severe Alopecia Areata: A Real-World Clinical Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132198

Registration Time: 2026/09/10

Type: Observational study

Primary Sponsor: Xi'an Jiaotong University Second Affiliated Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341789

Published by HT Digital Content Services with permission from Health Daily Digest....